Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Recovery quality with remimazolam tosilate vs other maintenance anesthesia regimens
ChiCTR2600126723Phase 4Not yet recruiting
- Sponsor
- Shunde Hospital of Guangzhou University of Chinese Medicine
- Start
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of remimazolam (2 arms), sponsored by Shunde Hospital of Guangzhou University of Chinese Medicine. Primary endpoint: Time from end of surgery to successful resuscitation. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
remimazolam
Beyond the preview
Go deeper on ChiCTR2600126723.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600126723.